Trial reportJournal of the Pediatric Infectious Diseases Society2026
Predictors of Sustained Viral Suppression among Children Living with HIV in Kenya: Secondary Analysis of Data from a Randomized Control Study.
Trial report in Journal of the Pediatric Infectious Diseases Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundViral suppression (VS) amongst children living with HIV (CLHIV) remains poor and several factors may affect sustained VS (SVS) over time.
methodsWe conducted a secondary analysis of data from a randomized control trial among CLHIV in western Kenya assessing individual, caregiver, and household factors associated with SVS, defined as viral load <1000 copies/mL throughout the study period of 12 months. We used multivariate logistic regression analysis, adjusting for additional covariates.
resultsA total of 668 CLHIV were included, median age of 9 years (interquartile range (IQR) 7-12) and time on antiretroviral treatment (ART) 6 years (IQR 3-8). Using a viral load (VL) cut off of 1000 copies/mL, the factors associated with lower odds of SVS were (1) self-reported child's poor ART adherence [adjusted odds ratio (AOR) 0.43; 95% CI, 0.27, 0.69]; (2) being on protease inhibitor-containing regimen [AOR 0.49 (0.31, 0.79)]; (3) spending less than 30 minutes travelling to the facility [AOR 0.59 (0.37, 0.95)] and (4) having more VL results available for analysis [AOR 0.80 (0.71, 0.90)]. At VL cut off of 200 and 50 copies/mL, being on PI containing regimen and travel duration to clinic were no longer associated with SVS. However, at VL cut off of 50 copies/mL, additional factors associated with lower odds of SVS were less than 2 years on ART [AOR 0.29 (0.14, 0.64)] and caregiver depression [AOR 0.61 (0.41, 0.91)].
conclusionThis analysis found that adherence on ART, years on ART, ART "anchor" drug, caregiver depression, travel duration to the health facility and number of VL assays were associated with SVS among CLHIV. Interventions to improve health outcomes for CLHIV should consider and address all relevant risk factors for viral non-suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.